Scleromyxedema: A multicenter study of characteristics, comorbidities, course, and therapy in 30 patients

Background Scleromyxedema is associated with a monoclonal gammopathy and other comorbidities. Its prognostic and therapeutic features are poorly documented because most reports deal with single cases or small series. Objective We sought to describe the characteristics of patients with scleromyxedema...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American Academy of Dermatology 2013-07, Vol.69 (1), p.66-72
Hauptverfasser:	Rongioletti, Franco, MD, Merlo, Giulia, MD, Cinotti, Elisa, MD, Fausti, Valentina, MD, Cozzani, Emanuele, MD, Cribier, Bernard, MD, Metze, Dieter, MD, Calonje, Eduardo, MD, Kanitakis, Jean, MD, Kempf, Werner, MD, Stefanato, Catherine M., MD, Marinho, Eduardo, MD, Parodi, Aurora, MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Comorbidity Dermatology dermatoneuro syndrome Female Glucocorticoids - therapeutic use Humans Immunoglobulins, Intravenous - therapeutic use Immunologic Factors - therapeutic use intravenous immunoglobulin Male Middle Aged monoclonal gammopathy mucinoses Paraproteinemias - epidemiology Prognosis Prospective Studies Remission Induction scleromyxedema Scleromyxedema - diagnosis Scleromyxedema - drug therapy Scleromyxedema - epidemiology Scleromyxedema - pathology Streptonigrin Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!